{
  "report_rows": [
    {
      "kpi": "Operating EBITDA (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$2,300M vs. cons $2,206M",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Net Revenue (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$12,200M vs. cons $11,980M",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Operating EPS (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$1.40 vs. cons $1.28",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Operating EBITDA (Q3 2026)",
      "prediction": "LOWER",
      "answer": "guide ~$2.0-2.1B vs. cons $2,197M",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Demand trajectory (H2 2026)",
      "prediction": "LOWER",
      "answer": "Cautious; pricing moderating from Q2 peak; June wildcard flagged",
      "confidence": "HIGH"
    },
    {
      "kpi": "T2O cost savings (H2 2026)",
      "prediction": "UNCHANGED",
      "answer": "Reaffirm $400M H2 ramp",
      "confidence": "HIGH"
    }
  ],
  "day1_residual_pct": -3.0,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -2.0,
  "day5_path": "STABILIZE",
  "day5_rationale": "STABILIZE \u2014 beat quality real but Q3 guide overhang prevents recovery; short covering limits further downside",
  "day5_confidence": "LOW"
}